Bills › 89th General Assembly
Relating to the decriminalization of certain schedule I controlled substances for the purposes of use by a patient diagnosed with a terminal illness or a life-threatening disease or condition
Topics:Health care
Where it is now
- Done: IntroducedFebruary 11, 2021
- Stopped: SubcommitteeDied when the General Assembly ended
- Next: House committee
- Next: Passes the House
- Next: Senate committee
- Next: Passes the Senate
- Next: To the Governor
- Next: Signed into law
Died when the session ended The 2022 session adjourned on May 24, 2022, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
This bill relates to the decriminalization of certain schedule I controlled substances for the purposes of use by a patient diagnosed with a terminal illness or a life-threatening disease or condition. Under the bill, the provisions of Code chapter 124 (controlled substances) including prohibited acts and penalties, do not apply to dimethyltryptamine (DMT); lysergic acid diethylamide (LSD); peyote; psilocybin; psilocyn; or MDMA when prescribed, possessed, handled, transported, delivered, or distributed by a health care provider or when possessed, handled, transported, or used by an eligible patient, in accordance with the bill.
Read the full explanation
Under the bill, an individual is an eligible patient if the individual has a terminal illness or a life-threatening disease or condition attested to by the individual’s treating health care provider; has considered and rejected or has tried and failed to respond to other treatment options approved by the United States food and drug administration; has received a recommendation from the individual’s treating health care provider for use of the controlled substance; has documentation from the individual’s treating health care provider that the individual meets these requirements; and has given written informed consent for the use of the controlled substance. The bill provides definitions for “eligible patient”, “health care provider”, “life-threatening disease or condition”, “terminal illness”, and “written informed consent”.